title: Pharma giants swap research programs.
abstract: Pharmaceutical giants Novartis and GlaxoSmithKline (GSK) agreed in late April to swap some assets, with Novartis handing off its vaccine business to GSK and getting most of the British company's cancer portfolio in return.
mesh_terms: D035843:Biomedical Research; D003132:Commerce; D004345:Drug Industry / Q000191:economics* / Q000458:organization & administration; D006801:Humans; D009369:Neoplasms / Q000191:economics; D014612:Vaccines / Q000191:economics
chemical_list: D014612:Vaccines